Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease
Georg Endler
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorAlexandra Klimesch
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorHeike Sunder-Plassmann
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorMartin Schillinger
Department of Internal Medicine II, Division of Angiology and,
Search for more papers by this authorMarkus Exner
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorChristine Mannhalter
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorNelli Jordanova
Department of Internal Medicine II, Division of Cardiology, AKH Wien, Universität Wien, Vienna, Austria
Search for more papers by this authorGünter Christ
Department of Internal Medicine II, Division of Cardiology, AKH Wien, Universität Wien, Vienna, Austria
Search for more papers by this authorRenate Thalhammer
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorKurt Huber
Department of Internal Medicine II, Division of Cardiology, AKH Wien, Universität Wien, Vienna, Austria
Search for more papers by this authorRaute Sunder-Plassmann
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorGeorg Endler
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorAlexandra Klimesch
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorHeike Sunder-Plassmann
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorMartin Schillinger
Department of Internal Medicine II, Division of Angiology and,
Search for more papers by this authorMarkus Exner
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorChristine Mannhalter
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorNelli Jordanova
Department of Internal Medicine II, Division of Cardiology, AKH Wien, Universität Wien, Vienna, Austria
Search for more papers by this authorGünter Christ
Department of Internal Medicine II, Division of Cardiology, AKH Wien, Universität Wien, Vienna, Austria
Search for more papers by this authorRenate Thalhammer
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorKurt Huber
Department of Internal Medicine II, Division of Cardiology, AKH Wien, Universität Wien, Vienna, Austria
Search for more papers by this authorRaute Sunder-Plassmann
University of Vienna Medical School, Department of Laboratory Medicine,
Search for more papers by this authorAbstract
Summary. After rupture of an arteriosclerotic plaque in a coronary artery, platelets play a crucial role in the subsequent thrombus formation, leading to myocardial infarction. An increased mean platelet volume (MPV), as an indicator of larger, more reactive platelets, may represent a risk factor for myocardial infarction. However, this hypothesis is still controversial and most studies addressing the role of MPV were performed comparing patients suffering from myocardial infarction with healthy controls. We intended to identify patients at high risk of suffering myocardial infarction in a group of patients with known coronary artery disease. One hundred and eighty-five consecutive patients with stable coronary artery disease were compared with 188 individuals who had suffered myocardial infarction. Patients within the highest quintile of MPV (≥ 11·6 fl) had a significantly higher risk of experiencing a myocardial infarction compared with patients within the lowest quintile (OR = 2·6, 95% CI 1·3–5·1) in a multivariate analysis that included sex, age, body mass index, hyperlipidaemia, hypertension, smoking and diabetes mellitus. Our results indicate that patients with pre-existing coronary artery disease and an increased MPV (≥ 11·6 fl) are at higher risk of myocardial infarction. These patients can be easily identified during routine haematological analysis and could possibly benefit from preventive treatment.
References
- Bath, P.M. (1993) The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Thrombosis and Haemostasis, 70, 687 – 690.
- Bath, P.M., Missouris, C.G., Buckenham, T. & MacGregor, G.A. (1994) Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis. Clinical Science, 87, 253 – 257.
- Brown, A.S., Hong, Y., De Belder, A., Beacon, H., Beeso, J., Sherwood, R., Edmonds, M., Martin, J.F. & Erusalimsky, J.D. (1997) Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 802 – 807.
- Corash, L., Tan, H. & Gralnick, H.R. (1977) Heterogeneity of human whole blood platelet subpopulations. Relationship between buoyant density, cell volume, and ultrastructure. Blood, 49, 71 – 87.
- Debili, N., Masse, J.M., Katz, A., Guichard, J., Breton-Gorius, J. & Vainchenker, W. (1993) Effects of the recombinant hematopoietic growth factors interleukin 3, interleukin 6, stem cell factor and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells. Blood, 82, 84 – 95.
- Endler, G., Exner, M., Mannhalter, C., Meier, S., Ruzicka, K., Handler, S., Panzer, S., Wagner, O. & Quehenberger, P. (2001) A common C − > T polymorphism at nt 46 in the promoter region of coagulation factor XII is associated with decreased factor XII activity. Thrombosis Research, 101, 255 – 260.DOI: 10.1016/S0049-3848(00)00404-7
- Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J.S., Humphries, S. & Woo, P. (1998) The effect of novel polymorphisms in the interleukin 6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation, 102, 1369 – 1376.
- Georges, J.L., Loukaci, V., Poirier, O., Evans, A., Luc, G., Arveiler, D., Ruidavets, J.B., Cambien, F. & Tiret, L. (2001) Interleukin 6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de L'infarctus du Myocarde. Journal of Molecular Medicine, 79, 300 – 305.
- Gladwin, A.M. & Martin, J.F. (1990) The control of megakaryocyte ploidy and platelet production: biology and pathology. International Journal of Cell Cloning, 8, 291 – 298.
- Halbmayer, W.M., Haushofer, A., Radek, J., Schon, R., Deutsch, M. & Fischer, M. (1995) Platelet size, fibrinogen and lipoprotein(a) in coronary heart disease. Coronary Artery Disease, 6, 397 – 402.
- Hoffman, R. & Long, M.W. (1995) Control of thrombocytopoiesis: current state of the art. Cancer Treatment Research, 80, 25 – 49.
- Jagroop, I.A. & Mikhailidis, D.P. (2000) Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan. Journal of Human Hypertension, 14, 581 – 585.
- Jagroop, I.A. & Mikhailidis, D.P. (2001) Doxazosin, an alpha1-adrenoceptor antagonist, inhibits serotonin-induced shape change in human platelets. Journal of Human Hypertension, 15, 203 – 207.
- Kario, K., Matsuo, T. & Nakao, K. (1992) Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clinical and Laboratory Haematology, 14, 281 – 287.
- Karpatkin, S. (1972) Biochemical and clinical aspects of megathrombocytes. Annals of the New York Academy of Science, 201, 262 – 279.
- Koenig, W. (1998) Epidemiology of coronary heart disease. Zeitschrift für Kardiologie, 87, 3 – 7.
- Lazzari, L., Henschler, R., Lecchi, L., Rebulla, P., Mertelsmann, R. & Sirchia, G. (2000) Interleukin 6 and interleukin 11 act synergistically with thrombopoietin andstem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells. Haematologica, 85, 25 – 30.
- Van Der Loo, B. & Martin, J.F. (1999) A role for changes in platelet production in the cause of acute coronary syndromes. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 672 – 679.
- McKarns, S.C., Smith, C.J., Payne, V.M. & Doolittle, D.J. (1995) Blood parameters associated with atherogenic and thrombogenic risk in smokers and nonsmokers with similar life-styles. Modern Pathology, 8, 434 – 440.
- Martin, J.F., Trowbridge, T. & Slater, D. (1983) Mean platelet volume in MI. British Medical Journal, 287, 1798.
- Martin, J.F., Bath, P.M. & Burr, M.L. (1991) Influence of platelet size on outcome after myocardial infarction. Lancet, 338, 1409 – 1411.
- Mathur, A., Robinson, M.S., Cotton, J., Martin, J.F. & Erusalimsky, J.D. (2001) Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction. Thrombosis and Haemostasis, 85, 989 – 994.
- Milner, P.C. & Martin, J.F. (1985) Shortened bleeding time in acute MI and its relation to platelet mass. British Medical Journal, 290, 1767 – 1770.
- O'Malley, T., Ludlam, C.A., Fox, K.A. & Elton, R.A. (1996) Measurement of platelet volume using a variety of different anticoagulant and antiplatelet mixtures. Blood Coagulation and Fibrinolysis, 7, 431 – 436.
- Pathansali, R., Smith, N.M. & Bath, P.M. (2001) Prothrombotic megakaryocyte and platelet changes in hypertension are reversed following treatment: a pilot study. Platelets, 12, 144 – 149.DOI: 10.1080/09537100120039000
- Pizzulli, L., Yang, A., Martin, J.F. & Luderitz, B. (1998) Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. European Heart Journal, 19, 80 – 84.
- Rabellino, E.M., Levene, R.B., Leung, L.L. & Nachman, R.L. (1981) Human megakaryocytes. II. Expression of platelet proteins in early marrowmegakaryocytes. Journal of Experimental Medicine, 154, 88 – 100.
- Ridker, P.M., Rifai, N., Stampfer, M.J. & Hennekens, C.H. (2000) Plasma concentration of interleukin 6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 101, 1767 – 1772.
- Rust, S., Funke, H. & Assmann, G. (1993) Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucleic Acids Research, 21, 3623 – 3629.
- Sharpe, P.C., Desai, Z.R. & Morris, T.C. (1994) Increase in mean platelet volume in patients with chronic renal failure treated with erythropoietin. Journal of Clinical Pathology, 47, 159 – 161.
- Smyth, D.W., Martin, J.F., Michalis, L., Bucknall, C.A. & Jewitt, D.E. (1993) Influence of platelet size before coronary angioplasty on subsequent restenosis. European Journal of Clinical Investigation, 23, 361 – 367.
- Trowbridge, E.A. & Martin, J.F. (1985) The relation of megakaryocyte ploidy to platelet volume. American Journal of Hematology, 18, 107 – 108.
- Trowbridge, E.A. & Martin, J.F. (1987) The platelet volume distribution: a signature of the prethrombotic state in coronary heart disease? Thrombosis and Haemostasis, 58, 714 – 717.
- Tschope, D., Langer, E., Schauseil, S., Rosen, P., Kaufmann, L. & Gries, F.A. (1989) Increased platelet volume – sign of impaired thrombopoiesis in diabetes mellitus. Klinische Wochenschrift, 67, 253 – 259.